Compare SABR & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SABR | MLAB |
|---|---|---|
| Founded | 2006 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Industrial Machinery/Components |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 652.0M | 489.8M |
| IPO Year | 2014 | 1995 |
| Metric | SABR | MLAB |
|---|---|---|
| Price | $1.60 | $77.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 1 |
| Target Price | $3.70 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 17.7M | 103.3K |
| Earning Date | 05-21-2026 | 05-04-2026 |
| Dividend Yield | N/A | ★ 0.82% |
| EPS Growth | ★ 283.56 | 99.24 |
| EPS | 1.34 | ★ 1.95 |
| Revenue | ★ $3,866,956,000.00 | N/A |
| Revenue This Year | $7.40 | $6.07 |
| Revenue Next Year | $3.26 | $5.41 |
| P/E Ratio | ★ $1.28 | $39.90 |
| Revenue Growth | ★ 7.46 | N/A |
| 52 Week Low | $0.81 | $59.63 |
| 52 Week High | $3.63 | $130.12 |
| Indicator | SABR | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 56.52 | 35.48 |
| Support Level | $1.20 | $77.23 |
| Resistance Level | $1.70 | $81.62 |
| Average True Range (ATR) | 0.20 | 4.13 |
| MACD | 0.04 | -2.09 |
| Stochastic Oscillator | 65.13 | 25.90 |
Sabre holds the number-two air booking volume share in the global distribution system industry. The distribution segment represented 80% of total 2025 revenue and airline IT solutions 20% of revenue. The company sold its growing hotel IT solutions division to TPG in 2025 for $960 million in net proceeds. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.